Goldman Sachs
BBH icon

Goldman Sachs’s VanEck Biotech ETF BBH Stock Holding History

Goldman Sachs’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.2M Hold
102,079
– – ﹤0.01% 2469
2025
Q4 		$19.3M Sell
102,079
-7,219
-7% -$1.34M ﹤0.01% 2412
2025
Q3 		$18.1M Sell
109,298
-673
-0.6% -$110K ﹤0.01% 2355
2025
Q2 		$16.9M Buy
109,971
+3,790
+4% +$564K ﹤0.01% 2277
2025
Q1 		$16.7M Sell
106,181
-15,900
-13% -$2.58M ﹤0.01% 2198
2024
Q4 		$19.2M Sell
122,081
-1,362
-1% -$229K ﹤0.01% 2169
2024
Q3 		$21.9M Buy
123,443
+10,741
+10% +$1.91M ﹤0.01% 1984
2024
Q2 		$19M Sell
112,702
-1,797
-2% -$294K ﹤0.01% 1931
2024
Q1 		$19M Buy
114,499
+1,619
+1% +$268K ﹤0.01% 1880
2023
Q4 		$18.7M Sell
112,880
-1,072
-0.9% -$165K ﹤0.01% 1966
2023
Q3 		$17.7M Sell
113,952
-2,038
-2% -$326K ﹤0.01% 1913
2023
Q2 		$18.1M Buy
115,990
+2,088
+2% +$334K ﹤0.01% 1936
2023
Q1 		$18.5M Buy
113,902
+1,022
+0.9% +$165K ﹤0.01% 1879
2022
Q4 		$18M Buy
112,880
+12,880
+13% +$2.04M ﹤0.01% 2059
2022
Q3 		$14.1M Sell
100,000
-5,524
-5% -$835K ﹤0.01% 2178
2022
Q2 		$15.4M Sell
105,524
-18,010
-15% -$2.68M ﹤0.01% 2119
2022
Q1 		$20M Hold
123,534
– – ﹤0.01% 2046
2021
Q4 		$23.4M Hold
123,534
– – ﹤0.01% 1977
2021
Q3 		$25M Buy
123,534
+6,922
+6% +$1.45M 0.01% 1865
2021
Q2 		$23.5M Sell
116,612
-2,830
-2% -$527K 0.01% 1904
2021
Q1 		$21M Buy
119,442
+50,000
+72% +$9.04M 0.01% 1891
2020
Q4 		$11.8M Buy
69,442
+19,442
+39% +$3.2M ﹤0.01% 2314
2020
Q3 		$8.1M Hold
50,000
– – ﹤0.01% 2505
2020
Q2 		$8.15M Hold
50,000
– – ﹤0.01% 2419
2020
Q1 		$6.4M Buy
+50,000
New +$6.73M ﹤0.01% 2447
2018
Q2 		– Sell
-3,538
Closed -$426K – 5655
2018
Q1 		$426K Buy
+3,538
New +$444K ﹤0.01% 4577
2017
Q4 		– Sell
-9,689
Closed -$1.3M – 6341
2017
Q3 		$1.3M Sell
9,689
-4,733
-33% -$616K ﹤0.01% 4353
2017
Q2 		$1.81M Sell
14,422
-57,519
-80% -$6.94M ﹤0.01% 3918
2017
Q1 		$8.56M Buy
71,941
+14,977
+26% +$1.75M ﹤0.01% 2523
2016
Q4 		$6.13M Sell
56,964
-44,939
-44% -$4.89M ﹤0.01% 2877
2016
Q3 		$11.7M Buy
101,903
+89
+0.1% +$10.1K ﹤0.01% 2325
2016
Q2 		$10.4M Sell
101,814
-29,438
-22% -$3.14M ﹤0.01% 2290
2016
Q1 		$13.6M Sell
131,252
-36
-0% -$3.75K ﹤0.01% 2001
2015
Q4 		$16.7M Sell
131,288
-1,202,788
-90% -$147M 0.01% 1880
2015
Q3 		$153M Buy
1,334,076
+134,660
+11% +$17.8M 0.05% 421
2015
Q2 		$162M Buy
1,199,416
+129,532
+12% +$17.2M 0.05% 421
2015
Q1 		$139M Buy
1,069,884
+424,169
+66% +$53.3M 0.04% 499
2014
Q4 		$74.5M Buy
645,715
+335,202
+108% +$37.8M 0.02% 842
2014
Q3 		$32.9M Buy
310,513
+160,024
+106% +$16.2M 0.01% 1408
2014
Q2 		$14.4M Sell
150,489
-26,127
-15% -$2.34M ﹤0.01% 2072
2014
Q1 		$16.1M Buy
176,616
+125,415
+245% +$12.2M 0.01% 1947
2013
Q4 		$4.53M Sell
51,201
-1,750
-3% -$146K ﹤0.01% 3177
2013
Q3 		$4.38M Sell
52,951
-9,868
-16% -$775K ﹤0.01% 3076
2013
Q2 		$4.3M Buy
+62,819
New +$4.37M ﹤0.01% 2896

Other funds holding BBH

Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CCA
Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return
PPWM
Paragon Private Wealth Management Lexington, Kentucky $320M AUM 23.48% 1-Year Est. Return

Goldman Sachs's BBH Position: Q1 2026 in Review

Goldman Sachs held its VanEck Biotech ETF (BBH) position steady in Q1 2026 at 102,079 shares worth $19.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2469.

Goldman Sachs first reported a position in BBH in Q2 2013 and has held it in 44 quarters since. The position peaked at $162M in Q2 2015. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

  • Goldman Sachs held 102,079 shares of VanEck Biotech ETF worth $19.2M as of Q1 2026.
  • Goldman Sachs left its VanEck Biotech ETF share count unchanged in Q1 2026.
  • VanEck Biotech ETF made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2469 holding.
  • Goldman Sachs first reported a position in VanEck Biotech ETF in Q2 2013 and has held it in 44 quarters since.
  • Goldman Sachs's VanEck Biotech ETF position peaked at $162M in Q2 2015.
  • 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.